GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Esperion Therapeutics Inc (LTS:0IIM) » Definitions » Forward Dividend Yield %

Esperion Therapeutics (LTS:0IIM) Forward Dividend Yield % : 0.00% (As of May. 02, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Esperion Therapeutics Forward Dividend Yield %?

As of today (2025-05-02), the Forward Annual Dividend Yield of Esperion Therapeutics is 0.00%.

As of today (2025-05-02), the Trailing Annual Dividend Yield of Esperion Therapeutics is 0.00%.

LTS:0IIM's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.885
* Ranked among companies with meaningful Forward Dividend Yield % only.

Esperion Therapeutics's Dividends per Share for the three months ended in Dec. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Esperion Therapeutics's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Esperion Therapeutics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Esperion Therapeutics's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Esperion Therapeutics's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Esperion Therapeutics's Forward Dividend Yield % falls into.


;
;

Esperion Therapeutics Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Esperion Therapeutics  (LTS:0IIM) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Esperion Therapeutics Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Esperion Therapeutics's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Esperion Therapeutics Business Description

Traded in Other Exchanges
Address
3891 Ranchero Drive, Suite 150, Ann Arbor, MI, USA, 48108
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Esperion Therapeutics Headlines

No Headlines